KCTD10 is a sensor for co-directional transcription-replication conflicts.

Saved in:
Bibliographic Details
Title: KCTD10 is a sensor for co-directional transcription-replication conflicts.
Authors: Kloeber JA; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.; Mayo Clinic Medical Scientist Training Program, Mayo Clinic, Rochester, MN, USA., Chen B; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Sun G; Advanced Diagnostic Laboratory, Quantitative Health Sciences Department, Mayo Clinic, Rochester, MN, USA., King CS; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Wang Z; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA., Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA., Wu Z; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Zhu S; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Zhao F; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Qin H; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Ouyang Y; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Xiao H; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Tu X; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Lu J; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Jiang Y; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Luo K; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Yin P; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Wu X; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA., Mutter RW; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA., Huang J; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA. huang.jinzhou@mayo.edu., Lou Z; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA. lou.zhenkun@mayo.edu.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA. lou.zhenkun@mayo.edu.
Source: Nature [Nature] 2025 Dec; Vol. 648 (8092), pp. 210-219. Date of Electronic Publication: 2025 Oct 08.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4687
DOI:10.1038/s41586-025-09585-9